BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21199719)

  • 1. Rituximab for uveitis.
    Miserocchi E; Pontikaki I; Modorati G; Bandello F; Meroni PL; Gerloni V
    Ophthalmology; 2011 Jan; 118(1):223-4. PubMed ID: 21199719
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.
    Miserocchi E; Pontikaki I; Modorati G; Gattinara M; Meroni PL; Gerloni V
    Autoimmun Rev; 2011 Nov; 11(1):35-9. PubMed ID: 21763790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121.
    Taupin P
    Expert Opin Ther Pat; 2011 Jan; 21(1):111-4. PubMed ID: 21155688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and complete resolution of lichen planopilaris in juvenile chronic arthritis treated with rituximab.
    Erras S; Mouna Z; Akhdari N; Belaabidia B; Essaadouni L
    Eur J Dermatol; 2011; 21(1):116-7. PubMed ID: 21300607
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab.
    Shimizu M; Kitagawa K; Nishio S; Yokoyama T; Furuichi K; Ohta K; Wada T; Yachie A
    Transpl Int; 2010 Sep; 23(9):e53-5. PubMed ID: 20536913
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab for noninfectious uveitis.
    Miserocchi E; Modorati G
    Dev Ophthalmol; 2012; 51():98-109. PubMed ID: 22517208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in IgG4-related inflammatory disease of the orbit and ocular adnexae.
    Lindfield D
    Eye (Lond); 2012 Oct; 26(10):1386. PubMed ID: 22814806
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of single-dose rituximab on primary glomerular diseases.
    Sugiura H; Takei T; Itabashi M; Tsukada M; Moriyama T; Kojima C; Shiohira T; Shimizu A; Tsuruta Y; Amemiya N; Ogawa T; Uchida K; Tsuchiya K; Nitta K
    Nephron Clin Pract; 2011; 117(2):c98-105. PubMed ID: 20693810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab.
    Schmidt E; Herzog S; Bröcker EB; Zillikens D; Goebeler M
    Br J Dermatol; 2005 Aug; 153(2):449-51. PubMed ID: 16086770
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of rheumatoid uveitis in children and teenagers].
    Denislam D; Constantin F
    Oftalmologia; 2005; 49(2):75-81. PubMed ID: 16245748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful adjuvant treatment of recalcitrant mucous membrane pemphigoid with anti-CD20 antibody rituximab.
    Taverna JA; Lerner A; Bhawan J; Demierre MF
    J Drugs Dermatol; 2007 Jul; 6(7):731-2. PubMed ID: 17763598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab as a treatment option for refractory endogenous anterior uveitis.
    Tappeiner C; Heinz C; Specker C; Heiligenhaus A
    Ophthalmic Res; 2007; 39(3):184-6. PubMed ID: 17534119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic lymphocytic leukemia-associated immune thrombocytopenia treated with rituximab: a retrospective study of 21 patients.
    D'Arena G; Capalbo S; Laurenti L; Del Poeta G; Nunziata G; Deaglio S; Spinosa G; Tarnani M; De Padua L; Califano C; Ferrara F; Cascavilla N
    Eur J Haematol; 2010 Dec; 85(6):502-7. PubMed ID: 20846302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab.
    Schmidt E; Benoit S; Bröcker EB; Zillikens D; Goebeler M
    Arch Dermatol; 2006 Feb; 142(2):147-50. PubMed ID: 16490841
    [No Abstract]   [Full Text] [Related]  

  • 15. Can rituximab induce long-term disease remission in patients with intra-ocular non-infectious inflammation?
    Tomkins-Netzer O; Taylor SR; Lightman S
    Ophthalmologica; 2013; 230(3):109-15. PubMed ID: 23948944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.
    Arnold DM; Crowther MA; Meyer RM; Carruthers J; Ditomasso J; Heddle NM; McLeod A; Kelton JG
    Transfusion; 2010 Dec; 50(12):2577-81. PubMed ID: 20576011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult orbital xanthogranuloma successfully treated with rituximab.
    Satchi K; McNab AA; Godfrey T; Prince HM
    Ophthalmology; 2014 Aug; 121(8):1664-5.e1-3. PubMed ID: 24811966
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective case review of pediatric patients with uveitis treated with infliximab.
    Rajaraman RT; Kimura Y; Li S; Haines K; Chu DS
    Ophthalmology; 2006 Feb; 113(2):308-14. PubMed ID: 16406545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab treatment for vasculitis.
    Jayne D
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1359-62. PubMed ID: 20671223
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab for thyroid eye disease.
    Oh SR; Priel A; Levi L; Granet DB; Korn BS; Kikkawa DO
    Ophthalmology; 2011 Apr; 118(4):792; author reply 792-3. PubMed ID: 21459230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.